Association between inflammatory gene polymorphisms and the risk of myocardial infarction

Russian Journal of Genetics

Volumn 50, Issue 2, 2014, Pages 211-217

  Nasibullin, T R ^a   Sadikova, R I ^a   Timasheva, Ya R ^a   Tuktarova, I A ^a   Erdman, V V ^a   Khusainova, L N ^b   Nikolaeva, I E ^c   Mustafina, O E ^a  

^a INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^b BASHKIR STATE MEDICAL UNIVERSITY   (Russian Federation)

^c Republican Cardiologic Dispensary   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; VASCULOTROPIN A;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA POLYMORPHISM; ELECTROPHORESIS; FISHER EXACT TEST; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 84895542915     PISSN: 10227954     EISSN: 16083369     Source Type: Journal    
DOI: 10.1134/S1022795414020112     Document Type: Article

References (35)

1. Ross, R., Atherosclerosis is an inflammatory disease, Am. Heart J., 1999, vol. 138, suppl., pp. S419-S420.
2. Libby, P., Inflammation in atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 2012, vol. 32, no. 9, pp. 2045-2051.
3. Stocker, C. J., Sugars, K. L., Harari, O. A., et al., TNF-alpha, IL-4, and IFN-gamma regulate differential expression of P and E-selectin expression by porcine aortic endothelial cells, J. Immunol., 2000, vol. 164, no. 4, pp. 3309-3315.
4. Pascerry, V., Willerson, J. T., and Yeh, E. Th., Direct proinflammatory effect of C-reactive protein on human endothelial cells, Circulation, 2000, vol. 102, no. 18, pp. 2165-2168.
5. Hayashidani, S., Tsutsui, H., Shiomi, T., et al., Antimonocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction, Circulation, 2003, vol. 108, no. 17, pp. 2134-2140.
6. Han, K. H., Tangirala, R. K., Green, S. R., and Quehenberger, O., Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes: a regulatory role for plasma LDL, Arterioscler. Thromb. Vasc. Biol., 1998, vol. 18, no. 12, pp. 1983-1991.
7. Qui, Y., Rui, Y. C., Zhang, L., et al., VEGF induced hyperpermeability in bovine aortic endothelial cell and inhibitory effect of salvianolic acid B, Acta Pharmacol. Sin., 2001, vol. 22, no. 2, pp. 117-120.
8. Inoue, M., Itoh, H., Tanaka, T., et al., Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma, Arterioscler. Thromb. Vasc. Biol., 2001, vol. 21, no. 4, pp. 560-566.
9. Eaton, C. B., Gramling, R., Parker, D. R., et al., Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England, Atherosclerosis, 2008, vol. 200, no. 1, pp. 221-227.
10. Sambrook, J., Fritsch, E. F., and Maniatis, T., Molecular Cloning: A Laboratory Manual, New York: Cold Spring Harbor Lab., 1989, 2nd ed.
11. Favorov, A. V., Andreewski, T. V., Sudomoina, M. A., et al., A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans, Genetics, 2005, vol. 171, no. 4, pp. 2113-2121.
12. McDermott, D. H., Yang, Q., Kathiresan, S., et al., CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study, Circulation, 2005, vol. 112, no. 8, pp. 1113-1120.
13. Weber, C., Zernecke, A., and Libby, P., The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models, Nat. Rev. Immunol., 2008, vol. 8, no. 10, pp. 802-815.
14. Schepers, A., Eefting, D., Bonta, P. I., et al., Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo, Arterioscler. Thromb. Vasc. Biol., 2006, vol. 26, no. 9, pp. 2063-2069.
15. Tatewaki, H., Egashira, K., Kimura, S., et al., Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation, J. Vasc. Surg., 2007, vol. 45, no. 6, pp. 1236-1243.
16. Jemaa, R., Ben Ali, S., Kallel, A., et al., Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients, Clin. Biochem., 2009, vol. 42, nos. 1-2, pp. 34-37.
17. Penz, P., Bucova, M., Lietava, J., et al., MCP-12518A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects, Bratisl. Lek. Listy, 2010, vol. 111, no. 8, pp. 420-425.
18. Bucova, M., Lietava, J., Mrazek, F., et al., The MCP-1-2518(A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population, Bratisl. Lek. Listy, 2009, vol. 110, no. 7, pp. 385-389.
19. Yuasa, S., Maruyama, T., Yamamoto, Y., et al., MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes, Diabetes Res. Clin. Pract., 2009, vol. 86, no. 3, pp. 193-198.
20. Luo, W., Wang, H., Ohman, M. K., et al., P-Selectin glycoprotein ligand-1 deficiency leads to cytokine resistance and protection against atherosclerosis in apolipoprotein E deficient mice, Atherosclerosis, 2012, vol. 220, no. 1, pp. 110-117.
21. Ruchaud-Sparagano, M. H., Malaud, E., Gayet, O., et al., Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis, Biochem. J., 1998, vol. 332, pp. 309-314.
22. Volcik, K. A., Ballantyne, Ch. M., Coresh, J., et al., Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the atherosclerosis risk in communities (ARIC) study, Atherosclerosis, 2007, vol. 195, no. 1, p. e76-e82.
23. Haidong Zhu, Weili Yan, Yuande Tan, et al., Adhesion molecule polymorphisms and pulse wave velocity in American youth, Twin Res. Hum. Genet., 2008, vol. 11, no. 5, pp. 517-523.
24. Kretowski, A. and Kinalska, I., L-Selectin gene T668C mutation in type 1 diabetes patients and their first degree relatives, Immunol. Lett., 2000, vol. 74, no. 3, pp. 225-228.
25. Russell, A. I., Graham, D. S. C., Chadha, S., et al., No association between E- and L-selectin genes and SLE: soluble L-selectin levels do correlate with genotype and a subset in SLE, Genes Immun., 2005, vol. 6, pp. 422-429.
26. Rozenberg, I., Sluka, S. H. M., Mocharla, P., et al., Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice, PLoS One, 2011, vol. 6, no. 7, p. e21675.
27. Jiang, H., Klein, R. M., Niederacher, D., et al., C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469): a risk factor for coronary heart disease and myocardial infarction, Int. J. Cardiol., 2002, vol. 84, nos. 2-3, pp. 171-177.
28. Buraczynska, M., Zaluska, W., Baranowicz-Gaszczyk, I., et al., The intercellular adhesion molecule-1 (ICAM-1) gene polymorphism K469E in end-stage renal disease patients with cardiovascular disease, Hum. Immunol., 2012, vol. 73, no. 8, pp. 824-828.
29. Ji, Y. N., Wang, Q., and Zhan, P., Intercellular adhesion molecule 1 gene K469E polymorphism is associated with coronary heart disease risk: a meta-analysis involving 12 studies, Mol. Biol. Rep., 2012, vol. 39, no. 5, pp. 6043-6048.
30. Sarecka-Hujar, B., Zak, I., and Krauze, J., Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease, Clin. Exp. Med., 2009, vol. 9, no. 2, pp. 117-124.
31. Podgoreanu, M. V., White, W. D., Morris, R. W., et al., Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery, Circulation, 2006, vol. 114, pp. I-275-I-281.
32. Bielinski, S. J., Reiner, A. P., Nickerson, D., et al., Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1), Atherosclerosis, 2011, vol. 216, no. 2, pp. 390-394.
33. Pare, G., Ridker, P. M., Rose, L., et al., Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci, PLoS Genet., 2011, vol. 7, no. 4, p. e1001374.
34. Bleda, S., De Haro, J., Varela, C., et al., Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in type II diabetic patients, Diabetes Vasc. Dis. Res., 2011, vol. 9, no. 1, pp. 68-74.
35. Yuan, Q., Zuo, X., and Jia, J., Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among northern Chinese Han, Neurosci. Lett., 2009, vol. 457, no. 3, pp. 133-136.